BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Leng SX, Margolick JB. Understanding frailty, aging, and inflammation in HIV infection. Curr HIV/AIDS Rep 2015;12:25-32. [PMID: 25656346 DOI: 10.1007/s11904-014-0247-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Pal VK, Agrawal R, Rakshit S, Shekar P, Murthy DTN, Vyakarnam A, Singh A. Hydrogen sulfide blocks HIV rebound by maintaining mitochondrial bioenergetics and redox homeostasis. Elife 2021;10:e68487. [PMID: 34792020 DOI: 10.7554/eLife.68487] [Reference Citation Analysis]
2 Freeman TL, Swartz TH. Purinergic Receptors: Elucidating the Role of these Immune Mediators in HIV-1 Fusion. Viruses 2020;12:E290. [PMID: 32155980 DOI: 10.3390/v12030290] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Zhang W, Li H, Bream JH, Nilles TL, Leng SX, Margolick JB. Longitudinal association of cytokine-producing CMV-specific T cells with frailty in HIV-infected and -uninfected men who have sex with men. Immun Ageing 2022;19:13. [PMID: 35255947 DOI: 10.1186/s12979-022-00270-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Fu Y, Zorman B, Sumazin P, Sanna PP, Repunte-Canonigo V. Epitranscriptomics: Correlation of N6-methyladenosine RNA methylation and pathway dysregulation in the hippocampus of HIV transgenic rats. PLoS One 2019;14:e0203566. [PMID: 30653517 DOI: 10.1371/journal.pone.0203566] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
5 Dunsmore G, Rosero EP, Shahbaz S, Santer DM, Jovel J, Lacy P, Houston S, Elahi S. Neutrophils promote T-cell activation through the regulated release of CD44-bound Galectin-9 from the cell surface during HIV infection. PLoS Biol 2021;19:e3001387. [PMID: 34411088 DOI: 10.1371/journal.pbio.3001387] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Lorenz DR, Mukerji SS, Misra V, Uno H, Gelman BB, Moore DJ, Singer EJ, Morgello S, Gabuzda D. Multimorbidity networks associated with frailty among middle-aged and older people with HIV. AIDS 2021;35:2451-61. [PMID: 34324449 DOI: 10.1097/QAD.0000000000003040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Levett TJ, Cresswell FV, Malik MA, Fisher M, Wright J. Systematic Review of Prevalence and Predictors of Frailty in Individuals with Human Immunodeficiency Virus. J Am Geriatr Soc 2016;64:1006-14. [PMID: 27225356 DOI: 10.1111/jgs.14101] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 7.6] [Reference Citation Analysis]
8 Iwasaki-Hozumi H, Chagan-Yasutan H, Ashino Y, Hattori T. Blood Levels of Galectin-9, an Immuno-Regulating Molecule, Reflect the Severity for the Acute and Chronic Infectious Diseases. Biomolecules 2021;11:430. [PMID: 33804076 DOI: 10.3390/biom11030430] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Kirk GD, Dandorf S, Li H, Chen Y, Mehta SH, Piggott DA, Margolick JB, Leng SX. Differential Relationships among Circulating Inflammatory and Immune Activation Biomediators and Impact of Aging and Human Immunodeficiency Virus Infection in a Cohort of Injection Drug Users. Front Immunol 2017;8:1343. [PMID: 29097998 DOI: 10.3389/fimmu.2017.01343] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
10 de Magalhães MC, Sánchez-Arcila JC, Lyra ACB, Long LFB, Vasconcellos de Souza I, Ferry FRA, de Almeida AJ, Alves-Leon SV. Hemostasis in elderly patients with human immunodeficiency virus (HIV) infection-Cross-sectional study. PLoS One 2020;15:e0227763. [PMID: 32049963 DOI: 10.1371/journal.pone.0227763] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Sánchez-Conde M, Rodriguez-Centeno J, Dronda F, López JC, Jiménez Z, Berenguer J, Pérez-Elías MJ, Moreno S, Rodés B, Brañas F. Frailty phenotype: a clinical marker of age acceleration in the older HIV-infected population. Epigenomics 2019;11:501-9. [PMID: 30675812 DOI: 10.2217/epi-2018-0130] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
12 Hussien H, Nastasa A, Apetrii M, Nistor I, Petrovic M, Covic A. Different aspects of frailty and COVID-19: points to consider in the current pandemic and future ones. BMC Geriatr 2021;21:389. [PMID: 34176479 DOI: 10.1186/s12877-021-02316-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Yap SH, Abdullah NK, McStea M, Takayama K, Chong ML, Crisci E, Larsson M, Azwa I, Kamarulzaman A, Leong KH, Woo YL, Rajasuriar R. HIV/Human herpesvirus co-infections: Impact on tryptophan-kynurenine pathway and immune reconstitution. PLoS One 2017;12:e0186000. [PMID: 29016635 DOI: 10.1371/journal.pone.0186000] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
14 Shears M, Takaoka A, Rochwerg B, Bagshaw SM, Johnstone J, Holding A, Tharmalingam S, Millen T, Clarke F, Rockwood K, Li G, Thabane L, Muscedere J, Stelfox HT, Cook DJ. Assessing frailty in the intensive care unit: A reliability and validity study. Journal of Critical Care 2018;45:197-203. [DOI: 10.1016/j.jcrc.2018.02.004] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 12.3] [Reference Citation Analysis]
15 Smit E, Wanke C, Dong K, Grotheer A, Hansen S, Skinner S, Tang AM. FRAILTY, FOOD INSECURITY, AND NUTRITIONAL STATUS IN PEOPLE LIVING WITH HIV. J Frailty Aging 2015;4:191-7. [PMID: 26689809 DOI: 10.14283/jfa.2015.50] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
16 Sauce D, Pourcher V, Ferry T, Boddaert J, Slama L, Allavena C. Immune activation and chronic inflammation: Is there an additional effect of HIV in a geriatric population? Medicine (Baltimore) 2021;100:e25678. [PMID: 33907138 DOI: 10.1097/MD.0000000000025678] [Reference Citation Analysis]
17 Szaniawski MA, Spivak AM. Senotherapeutics and HIV-1 Persistence. Curr HIV/AIDS Rep 2020;17:219-25. [PMID: 32356089 DOI: 10.1007/s11904-020-00496-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
18 Kojima G. Prevalence of frailty in end-stage renal disease: a systematic review and meta-analysis. Int Urol Nephrol 2017;49:1989-97. [PMID: 28229311 DOI: 10.1007/s11255-017-1547-5] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 6.4] [Reference Citation Analysis]
19 Nasi M, De Biasi S, Gibellini L, Bianchini E, Pecorini S, Bacca V, Guaraldi G, Mussini C, Pinti M, Cossarizza A. Ageing and inflammation in patients with HIV infection. Clin Exp Immunol 2017;187:44-52. [PMID: 27198731 DOI: 10.1111/cei.12814] [Cited by in Crossref: 113] [Cited by in F6Publishing: 106] [Article Influence: 18.8] [Reference Citation Analysis]
20 Heron SE, Elahi S. HIV Infection and Compromised Mucosal Immunity: Oral Manifestations and Systemic Inflammation. Front Immunol 2017;8:241. [PMID: 28326084 DOI: 10.3389/fimmu.2017.00241] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
21 Armstrong AJS, Quinn K, Fouquier J, Li SX, Schneider JM, Nusbacher NM, Doenges KA, Fiorillo S, Marden TJ, Higgins J, Reisdorph N, Campbell TB, Palmer BE, Lozupone CA. Systems Analysis of Gut Microbiome Influence on Metabolic Disease in HIV-Positive and High-Risk Populations. mSystems 2021;6:e01178-20. [PMID: 34006628 DOI: 10.1128/mSystems.01178-20] [Reference Citation Analysis]
22 Elahi S, Weiss RH, Merani S. Atorvastatin restricts HIV replication in CD4+ T cells by upregulation of p21. AIDS 2016;30:171-83. [PMID: 26645604 DOI: 10.1097/QAD.0000000000000917] [Cited by in Crossref: 44] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]
23 Rodríguez-Mora S, Spivak AM, Szaniawski MA, López-Huertas MR, Alcamí J, Planelles V, Coiras M. Tyrosine Kinase Inhibition: a New Perspective in the Fight against HIV. Curr HIV/AIDS Rep 2019;16:414-22. [PMID: 31506864 DOI: 10.1007/s11904-019-00462-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
24 Leng SX, Margolick JB. Aging, sex, inflammation, frailty, and CMV and HIV infections. Cell Immunol 2020;348:104024. [PMID: 31843200 DOI: 10.1016/j.cellimm.2019.104024] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
25 Szaniawski MA, Spivak AM. Senotherapeutics for HIV and aging. Curr Opin HIV AIDS 2020;15:83-93. [PMID: 31833962 DOI: 10.1097/COH.0000000000000609] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
26 Brunt SJ, Cysique LA, Lee S, Burrows S, Brew BJ, Price P. Short Communication: Do Cytomegalovirus Antibody Levels Associate with Age-Related Syndromes in HIV Patients Stable on Antiretroviral Therapy? AIDS Res Hum Retroviruses 2016;32:567-72. [PMID: 26876416 DOI: 10.1089/AID.2015.0328] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
27 Mullis C, Swartz TH. NLRP3 Inflammasome Signaling as a Link Between HIV-1 Infection and Atherosclerotic Cardiovascular Disease. Front Cardiovasc Med 2020;7:95. [PMID: 32596261 DOI: 10.3389/fcvm.2020.00095] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Lorenz DR, Mukerji SS, Misra V, Uno H, Gelman BB, Moore DJ, Singer EJ, Morgello S, Gabuzda D. Predictors of Transition to Frailty in Middle-Aged and Older People With HIV: A Prospective Cohort Study. J Acquir Immune Defic Syndr 2021;88:518-27. [PMID: 34757975 DOI: 10.1097/QAI.0000000000002810] [Reference Citation Analysis]
29 Pena Dias J, Haberlen SA, Dobs AS, Lake JE, Palella FJ, Kingsley LA, Price JC, Basaria S, Varadhan R, Margolick JB, Thio CL, Brown TT. Longitudinal Changes in Sex Hormone-Binding Globulin in Men With HIV. J Acquir Immune Defic Syndr 2021;87:1178-86. [PMID: 33990494 DOI: 10.1097/QAI.0000000000002723] [Reference Citation Analysis]
30 Bristow C, George G, Hillsmith G, Rainey E, Urasa S, Koipapi S, Kisoli A, Boni J, Saria GA, Ranasinghe S, Joseph M, Gray WK, Dekker M, Walker RW, Dotchin CL, Mukaetova-Ladinska E, Howlett W, Makupa P, Paddick SM. Low levels of frailty in HIV-positive older adults on antiretroviral therapy in northern Tanzania. J Neurovirol 2021;27:58-69. [PMID: 33432552 DOI: 10.1007/s13365-020-00915-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Vecchio A, Nakigozi G, Nakasujja N, Kisakye A, Batte J, Mayanja R, Anok A, Robertson K, Wawer MJ, Sacktor N, Rubin LH, Saylor D. Assessment, prevalence, and correlates of frailty among middle-aged adults with HIV in rural Uganda. J Neurovirol 2021;27:487-92. [PMID: 33788138 DOI: 10.1007/s13365-021-00969-x] [Reference Citation Analysis]
32 Puts MT, Toubasi S, Atkinson E, Ayala AP, Andrew M, Ashe MC, Bergman H, Ploeg J, McGilton KS. Interventions to prevent or reduce the level of frailty in community-dwelling older adults: a protocol for a scoping review of the literature and international policies. BMJ Open 2016;6:e010959. [PMID: 26936911 DOI: 10.1136/bmjopen-2015-010959] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]